Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Endocr Relat Cancer. 2011 Jan 13;18(1):171–180. doi: 10.1677/ERC-10-0248

Table 1.

Recurrent copy-number variant (CNV) regions identified in cases but absent in controlsa

CNV Regiona Case CNVs Carcinoid Control CNVs Additional population- based control CNVsb CNV Type Gene contents Addn contrlsd Addn controlse
Chr9: 137.3Mb-137.4 Mb 4/239 0/107 11/1512 Duplication C9orf62 11/871 22/2621
Chr10: 81.6-81.9 Mb 3/239 0/107 7/1512 Both§ SFTPD, C10orf57, Plac9 1/871 46/2621 (7 duplications and 39 deletions)
Chr16: 15.4-16.8 Mb 2/239 0/107 2/1512 Duplication C16orf45, KIAA0430, NDE1, MYH11, C16orf63, ABCC1, ABCC6 1/871 84/2621
Chr18: 64.00-64.04 Mb 5/239 0/107 0/1512 Deletion Intergenic 9/871 24/2621
a

This is the minimum region of overlap for all case CNVs aligned to hg18/Build 36.

b

These are Caucasian samples genotyped on Illumina 370K chips for another study. Listed CNVs must have at least 50% overlap with the defined case CNV region (i.e. column 1).

c

Two cases showed duplication of this locus and one showed deletion. All seven population-based control CNVs were duplications

d

Controls from meningioma data genotyped on Illumina 610-Quad

e

Controls from the schizophrenia/bipolar dbGaP dataset on the Affymetrix 6.0 chip